TAKUNG ART CO LTD (TKAT)       1.97  +0.05 (+2.6%)

1.97  +0.05 (+2.6%)

US87407Q2075 - Common Stock - After market: 1.97 0 (0%)


Fundamental Rating

Overall TKAT gets a fundamental rating of 1 out of 10. We evaluated TKAT against 81 industry peers in the Interactive Media & Services industry. TKAT has a bad profitability rating. Also its financial health evaluation is rather negative. TKAT is valued expensive and it does not seem to be growing.

Note: TKAT has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating


The Piotroski-F score of TKAT is 4.00. This is a neutral score and indicates average health and profitability for TKAT.
TKAT has negative profitability rations, so we won't be analyzing them here.

TKAT has a Return On Assets of -299.53%. This is below the industry average of -6.60%. 97% of the industry peers outperform TKAT.
TKAT has a Profit Margin of -1035.16%. This is below the industry average of -10.81%. 94% of the industry peers outperform TKAT.
VS Industry

ROA (-299.53%) VS Industry: 3% outperformed.

-647.52
40.84

Profit Margin (-1035.16%) VS Industry: 6% outperformed.

-1,540,816.67
106.50

Valuation

Valuation Rating


The Price/Earnings Ratio is negative for TKAT. In the last year negative earnings were reported.
With a price book ratio of 24.16, TKAT is valued rather expensively.

Compared to an average industry price book ratio of 2.11, TKAT is valued more expensive than its industry peers. 98% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Book (24.16) VS Industry: 2% outperformed.

110.10
0.14

Growth

Growth Rating


TKAT shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.17%.
TKAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3190.28%.

The Revenue for TKAT have been decreasing by -63.74% on average. This is quite bad

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -3190.28% N/A N/A N/A N/A
Revenue-63.74% -75.83% 23.17% N/A N/A N/A N/A

Health

Health Rating


The Debt to Equity ratio of TKAT is in line with the industry averages.
TKAT has a Piotroski-F score of 4.00. This indicates an average health and profitability for TKAT.
TKAT has a Current Ratio of 0.35. This is a bad value and indicates that TKAT is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Current Ratio of 2.12, TKAT is worse placed to pay its short term obligations than its industry peers. 97% of its industry peers have a better Current Ratio.

A Quick Ratio of 0.35 indicates that TKAT may have some problems paying its short term obligations.
When comparing the Quick Ratio of TKAT to the average industry Current Ratio of 2.12, TKAT is less able to pay its short term obligations than its industry peers. 97% of its industry peers have a better Quick Ratio.
TKAT has an Altman-Z score of -6.84. This is a bad value and indicates that TKAT is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 1.49, TKAT is in worse financial state than most of its industry peers. 91% of its industry peers have a better Altman-Z score.
VS Industry

Debt/Equity (0) VS Industry: 53% outperformed.

57.81
0.00

Quick Ratio (0.35) VS Industry: 3% outperformed.

0.03
21.62

Current Ratio (0.35) VS Industry: 3% outperformed.

0.03
21.78

Altman-Z (-6.84) VS Industry: 9% outperformed.

-239.83
18.08

Dividend

Dividend Rating


No dividends for TKAT!.

TKAT Daily chart

TAKUNG ART CO LTD1.97

NYSEARCA:TKAT (8/16/2022, 7:04:00 PM)+0.05 (+2.6%)

After market: 1.97 0 (0%)

Chartmill FA Rating
GICS Sector Communication Services
GICS IndustryGroup Media & Entertainment
GICS Industry Interactive Media & Services
Earnings (Last) N/A N/A Earnings (Next) 08-23 2022-08-23/bmo
Ins Owners N/A Inst Owners 0.92%
Market Cap 48.48M Analysts N/A
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 12.52 P/B 24.16
EV/EBITDA N/A
Profitability
ROA -299.53% ROE N/A
PM -1035.16 Asset Turnover 0.29
Growth
EPS 1Y -3190.28% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -8.38%
EPS Next Y N/A EPS Next 2Y N/A
EPS Next 3Y N/A EPS Next 5Y N/A
Revenue growth 1Y 23.17% Revenue growth 3Y -75.83%
Revenue growth 5Y -63.74% Revenue growth Q2Q -100%
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
Health
Current Ratio 0.35 Quick Ratio 0.35
Altman-Z -6.84 F-Score 4
Debt/Equity 0
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA